DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Market Assessment

Get the full story of a disease with insights powered by primary market research, real world data, and disease-area expertise directly from within the Market Assessment Insights Platform

 

Request a Demo

 

Epidemiology

Gain insight into epidemiology covering 170+ indications and biomarkers, 45 countries, and 3,500+ subpopulations

Forecasting

Understand disease-specific markets and therapies, including sales forecasts by branded or generic/biosimilar drug, class, and type

Disease Management

Discover current and predicted treatment protocols, prescribing behaviors, and the detailed patient journey, for a wide range of indications

DRG’s Market Assessment solutions illuminate brand usage across different lines of therapy, identifying opportunities for increased market positions and highlighting unmet needs that can translate into commercial opportunities, enabling you to maximize market share.

Explore our Market Assessment Solutions

Disease Landscape & Forecasting

10-year market outlooks and bottom-up forecasts for drugs on the market and in research & development

Learn more

Epidemiology

Gold-standard patient population sizing data, covering 165+ diseases and biomarkers, 45 countries and 3,500+ patient subpopulations.

Learn more

Unmet Need

Primary research and conjoint analysis with high-prescribing physicians to determine the most commercially viable unmet needs that exist within a disease market.

Learn more

Current Treatment: Physician Insights

In-depth, primary market research directly from physicians to uncover the ‘why’ and ‘how’ behind prescribing decisions, attitudes, and behaviors in a given disease market.

Learn more

Treatment Algorithms: Claims Data Analysis

Detailed analysis of brand usage across different lines of therapy, using real-world data to accurately assess your source of business and quantify areas of opportunity for increasing brand share

Learn more

Treatment Sequencing

Sequential treatment patterns in patient populations through physician insights, drug share mapped to treatment journey, and market-relevant treatment scenarios from world-class oncology experts.

Learn more

Patient Profiler

Disease-specific, patient-level analysis of the key demographic, clinical, and cost-based metrics underlying brand use, all sourced with DRG’s comprehensive Real World Data repository.

Learn more

Real World Brand Tracker

U.S. claims data in real time uncovers shifting market dynamics and the impact of events on the immune checkpoint inhibitor space.

Learn more

Emerging Therapies

Physician insights on adoption, trial, and usage of newly launched therapies and their impact on market dynamics within the first year of launch.

Learn more

Access & Reimbursement

Therapy-level market access insights across the US, EU5, and select emerging markets, based on primary market research with local physicians and payers.

Learn more

Oncology Clinical Trial Monitor

Helps companies access, visualize, and interpret data to uncover key trends in trial design and identify future pipeline opportunities in oncology.

Learn more

Biosimilars Insights

Analysis of the evolving biosimilar market landscape, including evaluation of risks, opportunities, and strategies underlying biosimilars development and reference brand defense.

Learn more

Company & Drug Insights

Competitive analysis of the global pharmaceutical market using top-down, company-reported sales data for forecasts by brand, therapy area, and company.

Learn more